SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-22-001569
Filing Date
2022-11-09
Accepted
2022-11-09 07:30:44
Documents
13
Period of Report
2022-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MIRUM PHARMACEUTICALS, INC. 8-K a52964746.htm   iXBRL 8-K 26484
2 EXHIBIT 99.1 a52964746ex99_1.htm EX-99.1 147139
  Complete submission text file 0001157523-22-001569.txt   326158

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20221109.xsd EX-101.SCH 3932
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20221109_lab.xml EX-101.LAB 23288
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20221109_pre.xml EX-101.PRE 16556
7 EXTRACTED XBRL INSTANCE DOCUMENT a52964746_htm.xml XML 4390
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 221370669
SIC: 2834 Pharmaceutical Preparations